GLYCOCALICIN LEVELS IN THE PLASMA OF HIV- AN INDICATOR OF PLATELET TURNOVER( PATIENTS )

Citation
Sb. Williams et al., GLYCOCALICIN LEVELS IN THE PLASMA OF HIV- AN INDICATOR OF PLATELET TURNOVER( PATIENTS ), The Journal of laboratory and clinical medicine, 132(4), 1998, pp. 303-307
Citations number
11
Categorie Soggetti
Medicine, General & Internal","Medicine, Research & Experimental","Medical Laboratory Technology
ISSN journal
00222143
Volume
132
Issue
4
Year of publication
1998
Pages
303 - 307
Database
ISI
SICI code
0022-2143(1998)132:4<303:GLITPO>2.0.ZU;2-O
Abstract
Glycocalicin (GC) is the carbohydrate-rich portion of platelet membran e glycoprotein Ib alpha that can be cleaved from circulating platelets by proteases. The plasma GC level is an indicator of platelet turnove r, Using an ELISA for GC, we assayed the plasma of 20 normal children (age 6 to 13 years), 50 HIV+ children (ages 4 to 18 years), 32 normal adults (ages 21 to 53 years), and 50 HIV+ adults (ages 24 to 66 years) . The results were adjusted for individual platelet counts to give GC indexes (GCI). The normal children and the normal adults had significa ntly different GCI distributions (P = .002). In both normal and HIV+ i ndividuals the GCI decreased with increasing platelet count (-.73 < r < -.34). Twenty-eight percent of the HIV+ children and 28% of the HIV adults had elevated GCI values, The majority of these elevated values occurred in patients with platelet counts >100,000/mu L. Neither the GCI nor the platelet count was correlated with viral load, The platele t count, however, was weakly correlated with the CD4 count in both chi ldren (r = .31) and adults (r = .30) infected with HIV. Also, the CD4 count was weakly and inversely correlated with GCI in HIV+ adults (r = -.34) and in children (r = -.24). We conclude that increased GCI and, by implication, increased platelet turnover is a relatively common fe ature of advanced HIV disease. Furthermore, GCI may be elevated in HIV + patients even with a platelet count >100,000/mu L, suggesting increa sed platelet turnover before thrombocytopenia develops.